.jpg?format=webp&width=780)
The study evaluates the effectiveness of continuous positive airway pressure (CPAP) treatment on albuminuria progression in patients with obstructive sleep apnea (OSA) and diabetic kidney disease (DKD). The study found that while CPAP treatment did not significantly affect albuminuria in all patients, it effectively reduced urinary albumin-to-creatinine ratios (UACR) in patients who were non-sleepy with severe OSA, worse renal function, and a shorter DKD evolution time. However, there are limitations to the study, such as missing data and differences in variables at baseline, and further research is needed to determine the long-term effects of CPAP therapy. The article also suggests ways to address the problem of poor CPAP adherence and the need for early intervention and treatment adherence.
Like
Save
Share